111In-pentetreotide scintigraphy in thyroid-associated orbitopathy

被引:0
作者
Bockisch, A
Kahaly, GJ
Görges, R
机构
[1] Univ Hosp Essen, Clin Nucl Med, Essen, Germany
[2] Univ Mainz, Dept Clin Endocrinol, D-6500 Mainz, Germany
关键词
pentetreotide; thyroid-associated orbitopathy;
D O I
10.1055/s-0029-1212181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:S184 / S185
页数:2
相关论文
共 13 条
[1]   Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy [J].
Colao, A ;
Lastoria, S ;
Ferone, D ;
Pivonello, R ;
Macchia, PE ;
Vassallo, P ;
Bonavolontá, G ;
Muto, P ;
Lombardi, G ;
Fenzi, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11) :3790-3794
[2]  
FORSTER GJ, IN PRESS THYROID
[3]   Octreotide-scintigraphy is a disease-activity parameter in Graves' ophthalmopathy [J].
Gerding, MM ;
van der Zant, FM ;
van Royen, EA ;
Koornneef, L ;
Krenning, EP ;
Wiersinga, WM ;
Prummel, MF .
CLINICAL ENDOCRINOLOGY, 1999, 50 (03) :373-379
[4]   ROLE OF OCTREOSCAN AND CORRELATION WITH MR-IMAGING IN GRAVES OPHTHALMOPATHY [J].
KAHALY, G ;
DIAZ, M ;
JUST, M ;
BEYER, J ;
LIEB, W .
THYROID, 1995, 5 (02) :107-111
[5]  
KAHALY G, 1995, J NUCL MED, V36, P550
[6]  
Kahaly G, 1998, J NUCL MED, V39, P533
[7]   Somatostatin receptor scintigraphy in thyroid eye disease [J].
Kahaly, GJ ;
Forster, GJ .
THYROID, 1998, 8 (06) :549-552
[8]   The role of octreoscan in thyroid eye disease [J].
Krassas, GE ;
Kahaly, GJ .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1999, 140 (05) :373-375
[9]   Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease [J].
Krassas, GE ;
Doumas, A ;
Kaltsas, T ;
Halkias, A ;
Pontikides, N .
THYROID, 1999, 9 (01) :47-52
[10]   SOMATOSTATIN RECEPTOR SCINTIGRAPHY AND OCTREOTIDE TREATMENT IN PATIENTS WITH THYROID EYE DISEASE [J].
KRASSAS, GE ;
DUMAS, A ;
PONTIKIDES, N ;
KALTSAS, T .
CLINICAL ENDOCRINOLOGY, 1995, 42 (06) :571-580